Pacira BioSciences, Inc. Common Stock PCRX
$23.00
-0.78%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (3 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $29.80
- Implied Upside
- +29.6%
- Price Target Range
- $25.00 – $38.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-05 | RBC CapitalDouglas Miehm |
Maintains | Sector perform | $24 → $25 |
| 2026-08-05 | NeedhamSerge Belanger |
Maintains | Buy | $32 → $33 |
| 2026-07-01 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $38 |
| 2026-05-01 | RBC CapitalDouglas Miehm |
Maintains | Sector perform | $22 → $24 |
| 2026-05-01 | NeedhamSerge Belanger |
Maintains | Buy | $30 → $32 |
| 2026-03-26 | BarclaysGlen Santangelo |
Maintains | Equal-weight | $27 → $25 |
| 2026-01-09 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $38 |
| 2026-01-09 | NeedhamSerge Belanger |
Maintains | Buy | $30 |
| 2025-12-09 | BarclaysGlen Santangelo |
Initiates coverage on | Equal-weight | $27 |
| 2025-11-17 | HC Wainwright & Co.Douglas Tsao |
Assumes | Buy | $38 |
| 2025-11-07 | Truist SecuritiesLes Sulewski |
Maintains | Buy | $30 → $28 |
| 2025-05-09 | NeedhamSerge Belanger |
Maintains | Buy | $32 → $30 |
| 2025-04-08 | NeedhamSerge Belanger |
Reiterates | Buy | $32 |
| 2025-04-08 | HC Wainwright & Co.Oren Livnat |
Maintains | Buy | $48 → $65 |
| 2025-02-28 | BarclaysBalaji Prasad |
Maintains | Overweight | $17 → $24 |
| 2025-02-28 | NeedhamSerge Belanger |
Maintains | Buy | $30 → $32 |
| 2025-02-28 | HC Wainwright & Co.Oren Livnat |
Maintains | Buy | $57 → $70 |
| 2025-01-30 | Truist SecuritiesLes Sulewski |
Upgrades | Sell → Hold | $8 → $25 |
| 2025-01-14 | RBC CapitalGregory Renza |
Reiterates | Sector perform | $18 |
| 2025-01-13 | NeedhamSerge Belanger |
Maintains | Buy | $22 → $30 |
| 2024-12-17 | NeedhamSerge Belanger |
Maintains | Buy | $22 → $30 |
| 2024-12-04 | HC Wainwright & Co.Oren Livnat |
Reiterates | Buy | $39 |
| 2024-11-12 | BarclaysBalaji Prasad |
Maintains | Equal-weight | $25 → $17 |
| 2024-11-08 | NeedhamSerge Belanger |
Reiterates | Buy | $22 |
| 2024-11-07 | RBC CapitalGregory Renza |
Maintains | Sector perform | $15 → $16 |
| 2024-10-04 | RBC CapitalGregory Renza |
Maintains | Sector perform | $14 → $15 |
| 2024-09-24 | JefferiesGlen Santangelo |
Maintains | Buy | $15 → $18 |
| 2024-08-13 | Truist SecuritiesLes Sulewski |
Downgrades | Buy → Sell | $30 → $8 |
| 2024-08-12 | RBC CapitalGregory Renza |
Downgrades | Outperform → Sector perform | $37 → $14 |
| 2024-08-12 | HC Wainwright & Co.Oren Livnat |
Maintains | Buy | $57 → $39 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $23.00
- Market Cap
- $944.73 million
- 52-Week Range
- $18.80 – $27.66
- Average Volume
- 643K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.